Asthma & COPD (2012)

SMi present their 8th annual Asthma & COPD event to be held in London on Monday 16th & Tuesday 17th of Apil 2012.  Building on the success of our previous Asthma & COPD, and COPD: Novel Therapeutics and Management Strategies events, this year will see an elite panel of speakers drawn for both industry and academia. The successful combination of academic KOLs and leading senior big Pharma speakers offers an ideal and comprehensive platform for the study of both Asthma & COPD. The similarities between the two conditions are juxtoposed with the the subtle and important differences. Both pose unique and complex challenges, and these differences must be identified and isolated. As respiratory research continues to grow and prosper this event contributes further towards the understanding of how they can be dealt with in a successful and cost effective manner. This event offers an ideal platform for those who have recently moved in to respiratory studies as well as established professionals. This is an opportunity to network with the leading protagonists in the field and to learn from their knowledge and experience as well as to share your own.

"The total financial burden of lung disease in Europe amounts to nearly €102 billion, a figure comparable to the annual gross domestic product (GDP) of the Republic of Ireland.
COPD contributes to almost one-half of this figure, followed by asthma, pneumonia, lung cancer and TB"

Source: http://www.european-lung-foundation.org/16-european-lung-foundation-elf-lung-diseases.htm